まとめ
薬剤だけでなく,新しい薬剤開発システムを開発することは,開発途上国における主要な病気に対処するために極めて重要です. このアプローチは,R&Dを特定の財務的および生物学的ニーズに合わせ,世界的な健康の公平性を改善します.
科学分野:
- グローバル・ヘルス グローバル・ヘルス
- 医薬品の研究開発について
- 医療技術評価について
背景:
- 疾病管理戦略は,先進国と発展途上国の間で大きく異なります.
- 現在の製薬業界の成功は,開発途上国の公衆衛生上の課題にあまり適用できない個別的に提供される治療法に焦点を当てている.
- 既存のR&Dモデルは,開発途上地域の病気のユニークな経済的および生物学的文脈を適切に扱っていない.
研究 の 目的:
- 開発途上国により良いサービスを提供するために,医薬品R&Dのパラダイムシフトを主張する.
- 低所得国の流行病に対処するために,新しい薬ではなく,新しいシステムが必要であることを強調する.
- 開発途上国の具体的な財政的,生物学的現実に合わせた研究開発の枠組みを提案する.
主な方法:
- 概念的分析と議論. 概念的分析と議論. 概念的分析と議論. 概念的分析と議論. 概念的分析と議論.
- 既存の疾病管理技術と医薬品の研究開発モデルのレビュー.
- 工業化国と開発途上国の保健需要の比較評価.
主要な成果:
- 医薬品業界の支配的な研究開発モデルは,開発途上国の主要な健康問題と整合していない.
- 最も重要な満たされていない需要は,新しい治療法ではなく,革新的なR&Dシステムです.
- 開発途上国の広範な疾病管理のために,財政的に実行可能で,生物学的に有効な医薬品を開発するために,カスタマイズされたR&Dシステムは不可欠です.
結論:
- 製薬業界は,世界的な健康格差を効果的に解決するために,研究開発システムを革新する必要があります.
- 開発途上国のための将来の薬物開発は,アクセスしやすい,グループ指向の,経済的に実現可能な解決策に焦点を当てることを要求します.
- R&Dプロセスの再考は,経済的に後退している地域における医薬品介入の影響を改善するために極めて重要です.
関連する概念動画
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:21Pharmacodynamics: Overview and Principles
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...